Training

As one of the nation’s leading safety advocates, the National Safety Council (NSC) spotlights issues in an effort to “eliminate preventable deaths at work, in homes and communities, and on the road through leadership, research, education and advocacy.” The organization has identified prescription drug misuse as one of its key safety issues because of the alarming rise in addiction rates, ER visits, overdoses, and fatalities. Dr. Don Teater, Medical Advisor for the National Safety Council, has emphatically stated, “Painkillers don’t kill pain. They kill people.”

This public safety issue also weighs heavily on the workplace, impacting more than 70 percent of U.S. employers. According to research published in The Clinical Journal of Pain, the non-medical use of prescription opioids cost the United States approximately $42 billion dollars in lost productivity in 2006. Five drugs in particular, OxyContin®, oxycodone, hydrocodone, propoxyphene, and methadone, accounted for two-thirds of the total economic burden.

The NSC reported results from its recent survey, which examined employers’ perceptions and experiences with prescription drugs. Because of substance misuse, employers face challenges with absenteeism, decreased job performance, injuries, positive drug test results, co-workers using, borrowing, or selling prescription drugs at work, and a negative impact on employee morale. In addition, the NSC survey data shows:

  • 81 percent of employers lack a drug-free workplace policy
  • 76 percent of employers do not offer training to identify drug misuse
  • 41 percent of employers do not drug test for synthetic opioids

Employers want to help employees, yet only 19 percent of employers answered that they were “extremely prepared” to deal with the misuse or abuse of prescription medications. Managers cited that they need additional clarification regarding policy, benefits, insurance, treatment options, and simply identifying warning signs of a potential problem.

How can the remaining 81 percent of employers get informed and gain confidence when facing this challenge? Survey authors suggest that companies add specialized workplace training for supervisors, implement drug testing programs, and strengthen their policies with more precise language about drug use without a prescription, employee impairment, and return-to-work protocols.

The NSC has amassed a comprehensive collection of resources such as drug fact sheets, strategy guides, videos, graphics, and survivor stories to bring greater awareness to the issue. Download the kit for employers.

Download our Drug Testing Guide.

To learn more about drug testing, visit our website or contact us online.

Collection Sites Outfitted for eCCF

by Nicole Jupe on February 5, 2016

collection-site-eccfAs we ramp up for the new Federal electronic Custody and Control Form (eCCF), developments and initiatives across our organization are nearly complete. After decades of using the traditional paper Custody and Control Form for drug testing ordering, specimen collection processing and chain of custody documentation for workplace drug testing, our collection sites are ready to use eCCF for regulated drug testing.

We have outfitted each of the more than 1,300 Quest Diagnostics Patient Service Centers (PSCs) in our nationwide drug testing collection network with bar code scanners and signature pads which will allow these sites to leverage Federal eCCF. This technology enables clear, readable images by eliminating the data entry and legibility errors associated with handwritten information on paper forms. Digital processes also offer improved speed and efficiency with less paperwork to manage.

In addition, we are upgrading our online collection software wizard for non-regulated drug testing to mirror Federal drug testing. Our wizard requires the collector to follow the same steps in the specimen collection process and perform all the necessary drug testing requirements. The consistency between both protocols will help us to offer a more seamless drug testing experience for every donor.

Once our laboratories are approved by the U.S. Department of Health and Human Services (HHS) National Laboratory Certification Program (NLCP), all of our PSCs that currently support drug testing collections will be eCCF-enabled for regulated drug testing. We have submitted documentation and anticipate our formal NLCP inspection to occur soon.

Our informational video will help to familiarize you with new terminology, show you the new Quest Diagnostics eCCF form and explain how eCCF can help to simplify the workplace drug testing process.

We will continue to share the latest updates on the Federal eCCF so that you and your organization can prepare to make the transition. To receive first alerts on the Federal eCCF, follow our blogbookmark our webpage or like us on LinkedIn and Facebook.

For more information about drug testing, visit our website or contact us online.

Updated Online Collection Training

May 4, 2010Collections

We are excited to rollout our new and improved Online Collection Training modules. Over the past several months we have worked to update the content, improve the flow, and to make these modules more user-friendly. Our Online Collection Training is a great way to train new hires or review the procedures for collecting urine, hair […]

Read the full article →

Updated Online Collection Training

March 17, 2010Online Solutions

We are excited to rollout our new and improved Online Collection Training modules. Over the past several months we have worked to update the content, improve the flow, and to make these modules more user-friendly. Our Online Collection Training is a great way to train new hires or review the procedures for collecting urine, hair […]

Read the full article →